| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/29/2001 | EP1127883A2 Oxamides as IMPDH inhibitors |
| 08/29/2001 | EP1127880A2 Phenylacetic acid derivatives substituted by a heterocycle and their use as A-II antagonists and as inhibitors of smooth muscle cell proliferation |
| 08/29/2001 | EP1127577A2 Ligand for the c-kit receptor and methods of use thereof |
| 08/29/2001 | EP1127115A1 Antisense oligomer |
| 08/29/2001 | EP1127110A1 Modified exosomes and uses |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/29/2001 | EP1127058A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 08/29/2001 | EP1127052A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 08/29/2001 | EP1127051A2 Tricyclic pyrazole derivatives |
| 08/29/2001 | EP1126860A2 Immunomodulatory factors for immunosuppressant and antiallergic treatment |
| 08/29/2001 | EP1126852A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 08/29/2001 | EP1126849A1 Heterocyclic potassium channel inhibitors |
| 08/29/2001 | EP1126842A2 Inhibition of the formation of vascular hyperpermeability |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP1126832A2 Conductance of improperly folded proteins through the secretory pathway |
| 08/29/2001 | EP1126826A1 Multiparticulate modified release composition |
| 08/29/2001 | EP1126823A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 08/29/2001 | CN1310708A Substituted phenylamidines with antithrombotic action |
| 08/29/2001 | CN1310707A Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicaments |
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/29/2001 | CN1310621A Substituted anilide compounds and methods |
| 08/29/2001 | CN1310179A Oxamide being as IMPDH inhibitor |
| 08/29/2001 | CN1310025A Therapeutical compound and its application |
| 08/29/2001 | CN1310003A Combined Chinese and Western medicine for treating pulmonary emphysema |
| 08/29/2001 | CN1310002A Combined Chinese and Western medicine for treating bronchial asthma |
| 08/29/2001 | CN1310001A Combined Chinese and Western medicine for treating chronic bronchitis in catabasis |
| 08/29/2001 | CN1309926A Preparation of additive for food, medicine and cosmetics and replenishing linolic acid and gamma-linolenic acid |
| 08/29/2001 | CN1070076C Medicine for treating cough & asthma and its producing method |
| 08/28/2001 | US6281363 Antiinflammatory agents; antiarthritic agents; autoimmune disorders |
| 08/28/2001 | US6281212 Chemokine receptor antagonists and methods of use therefor |
| 08/28/2001 | US6281205 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 08/28/2001 | US6280978 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 08/28/2001 | US6280971 Polynucleotide associated with detection of staphylococcus; for use in screening bactericides |
| 08/28/2001 | US6280755 To modulate metabolism of lipids in superficial mammalian tissues; in foods, drugs and cosmetics |
| 08/28/2001 | CA2107552C Use of deprenyl to maintain, prevent loss, or recover nerve cell function |
| 08/24/2001 | CA2337588A1 Oxamides as impdh inhibitors |
| 08/23/2001 | WO2001061356A1 Her-2 binding antagonists |
| 08/23/2001 | WO2001061055A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/23/2001 | WO2001061013A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001060837A2 Polypeptoid pulmonary surfactants |
| 08/23/2001 | WO2001060835A1 Purine derivatives |
| 08/23/2001 | WO2001060832A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 08/23/2001 | WO2001060825A1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 08/23/2001 | WO2001060821A1 Novel biarylcarboxamides |
| 08/23/2001 | WO2001060816A1 Kinase inhibitors |
| 08/23/2001 | WO2001060798A1 Amine derivatives for the treatment of apoptosis |
| 08/23/2001 | WO2001060778A2 Aspirin-triggered lipid mediators |
| 08/23/2001 | WO2001060414A2 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | WO2001060413A2 Recombinant vector expressing a beta2-adrenergic receptor and use in treating airway and vascular diseases |
| 08/23/2001 | WO2001060407A2 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 08/23/2001 | WO2001060405A1 Eosinophil-specific apoptosis inducer |
| 08/23/2001 | WO2001060363A1 A method for synthesizing leflunomide |
| 08/23/2001 | WO2001060358A1 Method and compositions for treating fibrotic diseases |
| 08/23/2001 | WO2001060349A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 08/23/2001 | WO2001060312A1 Device for calculating elixir doses appropriate for a patient's weight |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001010816A3 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/23/2001 | WO2000021514A3 Method and composition for treating and preventing tuberculosis |
| 08/23/2001 | WO2000006738A3 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 08/23/2001 | US20010016600 Method of treating cancer using dithiocarbamate derivatives |
| 08/23/2001 | US20010016596 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/23/2001 | US20010016583 Therapeutic application of pro-apoptotic benzodiazepines |
| 08/23/2001 | US20010016346 Pedtidyl-prolyl cis-trans isomerase inhibitors and uses therefore |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016207 Compounds such as N-(1-(cyanomethylcarbamoyl)cyclohexyl)-4-(piperazin-1-yl)-benzamide |
| 08/23/2001 | DE10007203A1 Composition for treating allergic and/or vasomotor rhinitis or allergic conjunctivitis by topical or oral administration, contains synergistic combination of non-sedating antihistamine and leukotriene antagonist |
| 08/23/2001 | CA2402477A1 Eosinophil-specific apoptosis inducer |
| 08/23/2001 | CA2400634A1 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | CA2400619A1 Purine derivatives |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400290A1 A method for synthesizing leflunomide |
| 08/23/2001 | CA2399757A1 Polypeptoid pulmonary surfactants |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2397651A1 Amine derivatives for the treatment of apoptosis |
| 08/23/2001 | CA2397233A1 Biarylcarboxamides |
| 08/22/2001 | EP1126022A2 Method of preserving white blood cells with CLA |
| 08/22/2001 | EP1125944A1 Pluraflavin and derivatives thereof, process for making them as well as their use |
| 08/22/2001 | EP1125936A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases |
| 08/22/2001 | EP1125925A1 Amine derivatives for the treatment of apoptosis |
| 08/22/2001 | EP1125580A2 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124964A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124848A2 Transmembrane 4 proteins |
| 08/22/2001 | EP1124845A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 08/22/2001 | EP1124837A2 Novel macrolide antibiotics |
| 08/22/2001 | EP1124829A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 08/22/2001 | EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/22/2001 | EP1124811A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124810A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124809A1 Benzoylpyridazines |
| 08/22/2001 | EP1124801A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 08/22/2001 | EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 08/22/2001 | EP1124779A1 Vitamin d analogues |
| 08/22/2001 | EP1124563A2 Methods and compositions for the prevention of tolerance to medications |